Pubblicazioni

Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study

2022 - ESMO OPEN

Procopio, G; Chiuri, V E; Giordano, M; Alitto, A R; Maisano, R; Bordonaro, R; Cinieri, S; Rossetti, S; De Placido, S; Airoldi, M; Galli, L; Gasparro, D; Ludovico, G M; Guglielmini, P F; Carella, C; Nova, P; Aglietta, M; Schips, L; Beccaglia, P; Sciarra, A; Livi, L; Santini, D